4-aminoquinazoline compound and preparation method and application thereof

A technology of aminoquinazolines and compounds, which is applied in the field of drug synthesis, and can solve the problems that anti-tumor drugs cannot meet the treatment requirements.

Inactive Publication Date: 2012-11-28
FUDAN UNIV
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The anticancer drugs currently used in clinical practice are far from meeting the requirements of treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 4-aminoquinazoline compound and preparation method and application thereof
  • 4-aminoquinazoline compound and preparation method and application thereof
  • 4-aminoquinazoline compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1: Synthesis of Compounds 1 , (3-ethynyl-phenyl)-{7-methoxy-6-[3-(2-oxa-6-aza-spiro[3.3]heptane-6-yl)-ethoxy] - Quinazolin-4-yl}-amine

[0039] 1) Synthesis of 6,7-dimethoxy-3H-quinazolin-4-one

[0040] Methyl 2-amino-4,5-dimethoxybenzoate (31.5g, 149.1mmol) and amine formate (9.45 g, 149.0 mmol) in formamide (105ml) were reacted by heating at 200 °C for 2 hours. Then cool to room temperature, filter the reaction solution, wash the filter cake with water, and dry to obtain the product (26.3 g, 85.6%).

[0041] 2) Synthesis of 6-hydroxy-7-methoxy-3H-quinazolin-4-one.

[0042] Add 6,7-dimethoxy-3H-quinazolin-4-one (26.3 g, 127.5 mmol) and L-methionine (22.8 g, 153.0 mmol) to a solution of methanesulfonic acid (175.0 mL) In the reaction bottle, then heated and stirred at 100 ° C for 22 hours to the end of the reaction. After cooling the reaction solution to room temperature, the reaction solution was poured into a container filled with 1L ice, and continued to...

Embodiment 2

[0058] Embodiment 2: synthetic compound 2 , (3-ethynyl-phenyl)-{7-methoxy-6-[2-(2-oxa-6-aza-spiro[3.3]heptane-6-yl)-propoxy] - Quinazolin-4-yl}-amine

[0059] Add [6-(3-bromo-propoxy)-7-methoxy-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine (50 mg), acetonitrile (10ml), Na 2 CO 3 (250 mg) and 2-oxa-6-aza-spiro[3.3]heptane oxalate (50 mg). The reaction was heated at 70°C for 1 hour and the product (34 mg) was obtained by preparative HPLC. LC-MS (m / z): 431(M+). 1 H NMR (d6-DMSO, 400 MHz): 1.81(t, J=6.4Hz, 2H), 2.49(m,2H), 3.28(s,4H), 3.94(s,3H), 4.15(t, J= 6.4Hz, 2H), 4.21(s,1H), 4.60(s,4H), 7.21(m,2H), 7.41(t, J=8Hz, 1H), 7.82-7.99(m,3H) , 8.50(s ,1H), 9.53(s,1H). 13 C NMR (CD 3 OD, 400 MHz): 26.71, 38.859, 55.126, 55.401, 62.938, 66.690, 77.360, 80.853, 82.992, 101.897, 105.757, 109.099, 122.774, 125.539, 127.237, 128.471, 139.282, 146.202, 148.962, 152.420, 155.321, 156.928 。

[0060]

Embodiment 3

[0061] Embodiment 3: synthetic compound 3 , {6-[3-(2-sulfone hetero-6-aza-spiro[3.3]heptane-6-yl)-propoxy]-7-methoxy-quinazolin-4-yl}- (3-Ethynyl-phenyl)-amine

[0062] Add [6-(3-bromo-propoxy)-7-methoxy-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine (50 mg), acetonitrile (10ml), Na 2 CO 3 (250 mg) and 2-sulfone-6-aza-spiro[3.3]heptane oxalate (50 mg). The reaction was heated at 70°C for 1 hour and the product (6 mg) was obtained by preparative HPLC. LC-MS (m / z): 479(M+). 1 H NMR (CD 3 OD, 400 MHz): 1.98(m, 2H), 2.75-2.79(m,2H), 3.52(m,4H), 4.01(s,3H), 4.23(m,2H), 4.30(m,4H), 7.19(s,1H), 7.21-7.29(m,1H), 7.40(t, J=8Hz, 1H), 7.74-7.80(m,2H), 7.93(m,1H), 8.45(s,1H). 13 C NMR (CD 3 OD, 400 MHz): 24.818, 26.760, 55.169, 64.065, 66.722, 72.952, 77.304, 102.015, 105.799, 109.179, 122.859, 125.684, 127.355, 128.513, 139.243, 146.322, 149.098, 152.490, 155.480, 157.116。

[0063]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of synthesis of medicaments, and relates to a 4-aminoquinazoline compound of a general formula (I), in particular to a 4-(3-acetenyl phenyl amino)-7-methoxy-quinazoline compound of which the 6th site is substituted by a quaternary heterocyclic ring, a preparation method for the compound and application in medicine. In vitro anti-tumor activity test results show that the compound has high anti-tumor activity and can be used for preparing new anti-tumor medicaments.

Description

technical field [0001] The invention belongs to the field of drug synthesis, and relates to a novel 4-aminoquinazoline compound, a preparation method and an application. In particular, it relates to a 4-(3-ethynylphenylamino)-7-methoxy-quinazoline compound substituted with a four-membered heterocycle at the 6-position, a preparation method thereof, and a medical application thereof. Background technique [0002] Malignant tumor has become a common disease that seriously endangers people's life and health. According to incomplete statistics, there are about 20 million new cases in the world every year; in my country, there are about 1.6-2 million new cases and 1.3 million deaths each year. Statistics show that due to the ability of tumors to metastasize in the early stage, about 50% of patients with clinically diagnosed primary tumors have developed distant metastases, and the tumor cells grow rapidly and easily mutate, resulting in multidrug resistance and failure of chemot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D491/107C07D495/10C07D405/12A61K31/517A61P35/00
Inventor 赵伟利董肖椿张卫星王锋李剑赵逸超赵风王雯
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products